You are here

Acute Cough Study In Children

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
DMI Research
Pinellas, Florida, 33782-4533 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Common Cold, Upper Respiratory Tract Infections
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
6-11 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Male or female healthy children ages 6 to under 12 years who are symptomatic with a cough
due to a cold or acute URTI characterized by:

- Onset of cold/URTI symptoms occurring no more than 10 days prior to Visit 1;

- At least 5 coughs during the second 30-minute period of the 60-minute baseline period.

General good health, aside from a common cold, and has no contraindications to the study or
rescue medication

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Acute, subchronic, or chronic cough due to any other condition other than a common
cold

History of clinically significant cardiovascular, pulmonary, hepatic, renal, neurological,
hematological, autoimmune, psychiatric, metabolic, gastro-intestinal or endocrine disease

NCT01257542
Pfizer
Terminated
Acute Cough Study In Children

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now